CSI Market
Sign In | Register

Caris Life Sciences Inc (CAI) Quarterly Cash Flow Statement

Quarterly · GAAP · USD millions
Access CAI Annual Cash Flow →
Observing cash flow movements over recent quarters helps explain how Caris Life Sciences Inc adapts cash usage as operating conditions change.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Quarterly Report, GAAP in USD millions
ITEM 		(Jun 30 2026)
6 Months 		(Mar 31 2026) (Dec 31 2025) (Sep 30 2025) (Jun 30 2025)
Operating Activities
Income-1.15
Depreciation & amortization11.60
Amortization of Other Assets2.92
Increase (Decrease) in Deferred Revenue0.00
Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Liability0.00
Provision For Loan Losses Expensed0.00
Increase (Decrease) in Materials and Supplies61.64
R & D, Environmental and Other Expense0.00
Gain (Loss) on Disposition of Property Plant Equipment, Excluding Oil and Gas Property and Timber Property0.00
Share-based Compensation38.09
Income (Loss) from Equity Method Investments0.00
Gains (Losses) on Extinguishment of Debt-25.23
Gains Losses On Sales Of Assets1.32
Gain Loss On Disposition Of Property-
Provision Recovery Of Doubtful Accounts-
Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest-
Net Investment In Sales Type And Direct Financing Leases-
Income taxes0.00
Gain (Loss) on Disposition of Stock in Subsidiary0.00
Increase (Decrease) in Accounts Receivable4.75
Increase (Decrease) in Accounts Payable39.63
Increase (Decrease) in Accrued Liabilities10.10
Deferred Revenue and Customer Advances and Deposits0.00
Increase (Decrease) in Prepaid Expense and Other Assets0.66
Other Working Capital0.77
Other Noncash Income (Expense)0.03
Other net0.00
Payments for (Proceeds from) Other Operating Activities-82.46
Discontinued operations0.00
Net Cash flow from Operating Activities61.35
Investing Activities
Capital Expenditures-32.42
Sale of Capital Items0.00
Short-term Investments Proceeds1.87
Short-term Investments Acq.-101.99
Real Estate Investments0.00
Receipt Of Principal Payments On Direct Financing And Sales Type Leases-
Increase (Decrease) in Restricted Cash0.00
Payments for (Proceeds from) Loans0.00
Payments for (Proceeds from) Deposits0.00
Payments for (Proceeds from) Other Investments0.00
Payments for (Proceeds from) Federal Reserve and FHLB0.00
Payments to Acquire Businesses, Net of Cash Acquired0.00
Interest in Subsidiaries and Affiliates0.00
Cash Divested from Deconsolidation0.00
Accounts payable0.00
Receivables0.00
Payments for (Proceeds from) Other Investing Activities0.00
Other Net0.00
Discontinued operations0.00
Net Cash Flow from Investing Activities-132.53
Financing Activities
Short-term debt Net0.00
Other borrowing transactions-1.11
Long-term debt - borrowings393.50
Long-term debt - repayments-406.31
Federal Home Loan Bank and Federal Funds0.00
Issuances / -repurchases of Comm. Stock-16.76
Partnership and Parent Transactions0.00
Issuances / -repurchases of Pref. Stock0.00
Deposits, Annuities, Contract Holders Funds0.00
Other financing activities net-5.32
Other net-0.08
Proceeds From Consolidated Vie-0.04
Proceeds From Long Term Credit Backed Line Of Credit Facility800.04
Principal Payments For Asset Long Term Debt-
Proceeds From Issuance Of Common And Preferred Stock-
Payments of Ordinary Dividends, Preferred Stock and Preference Stock0.00
Dividends paid0.00
Net Cash Flow from Financing Activities-36.08
Effect of exchange rate on cash flow0.00
Discontinued operations0.00
Free Cash Flow28.94
Total Cash Flow-107.30
4 historic quarters locked

Sign in to unlock the full Caris Life Sciences Inc cash flow history.

Sign In Create Free Account

About Caris Life Sciences Inc Quarterly Cash Flow Statement

What this statement shows

This page presents issuer-reported cash flow data, including operating, investing, financing, net, and free cash flow, as disclosed in SEC 10-Q filings and normalized by CSIMarket.

Source & verification

  • Form: 10-Q (Period: 20260630)
  • Filed with the SEC: August 5, 2026
  • Source: cai-20260630.htm

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - normalization in the CSIMarket.com database.
  • Accession: 0002019410-26-000055

Figures are derived from filed reports and may be restated. Historical data is subject to revision.